Clinical Trial Update: Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating HepaGam B in combination with antiviral therapy in hepatitis B patients who have undergone liver transplantation; study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HepaGam B (hepatitis B immune globulin)

Snippet

Sponsor: Cangene Corporation | Conditions: Hepatitis B, Liver Transplantation | Phase 4 | Status: COMPLETED